CRDLStock Financials & Fundamentals
Company Info
Company Full Name
Cardiol Therapeutics Inc Class A
Full name of the company.
Industry Name
Drug Manufacturers - Specialty & Generic
Industry name
Major Industry Name
Biotechnology
Major industry name
Sector Name
Healthcare
Sector name
Market Info
Current Price
$1.80
Current price of the stock
Trading Volume
$2M
Trading volume of the stock
Market Capitalization
$197.1M
Market capitalization of the company
Market Cap Category
Micro Cap
Category of market capitalization
Long-Term Growth Estimate
22.22%
Long-term growth mean estimate
Analyst Rating Mean
4.20
Mean analyst rating
Potential Upside
343.55%
Potential price appreciation based on analyst price targets
EPS Surprise Percentage Difference
-
Percentage difference of EPS surprise
Dividends
Dividend Change (1 Year)
-
Dividend change over 1 year
Dividend Rate
$0.00
Shows the amount of dividend paid
Balance Sheet
Total Debt to Equity Ratio
0.01
Total debt to total equity ratio
Current Ratio
4.16
Current ratio
Company Profitability
Gross Profit Margin
-
Gross profit margin
Operating Profit Margin
0.00%
Operating profit margin
EBIT Margin
0.00%
Earnings before interest and taxes (EBIT) margin
EBITDA Margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
Pretax Profit Margin
-
Pretax profit margin
Net Profit Margin
0.00%
Net profit margin
Return on Equity (ROE)
-1.74%
Measures profitability relative to shareholders' equity
Return on Tangible Equity
-189.17%
ROE excluding intangible assets
Return on Assets (ROA)
-78.25%
Measures profitability relative to total assets
Return on Invested Capital (ROIC)
-188.25%
Measures profitability relative to invested capital
Management Effectiveness
Asset Turnover (quarterly)
-
Asset turnover ratio
Inventory Turnover (quarterly)
-
Inventory turnover ratio
Receivables Turnover (quarterly)
-
Receivables turnover ratio
Days Sales Outstanding
-
Average number of days it takes to collect receivables
Valuation Measures
Price-to-Earnings (P/E) Ratio
-3.91
Measures valuation relative to earnings
Forward P/E Ratio
0.00
P/E based on future earnings estimates
Price-to-Sales (P/S) Ratio
1014.87
Measures valuation relative to sales
Price-to-Book (P/B) Ratio
9.77
Measures valuation relative to book value
Price-to-Operating Cash Flow (P/OCF) Ratio
-1.51
Measures valuation relative to operating cash flow
Price-to-Free Cash Flow (P/FCF) Ratio
-1.51
Measures valuation relative to free cash flow
Cash Flow Statement
Net Acquisitions/Divestitures
0
Indicates company's M&A activity
CRDLStock Financials & Fundamentals
Company Info
| Parameter | Value | Description |
|---|---|---|
| Company Full Name | Cardiol Therapeutics Inc Class A | Full name of the company. |
| Industry Name | Drug Manufacturers - Specialty & Generic | Industry name |
| Major Industry Name | Biotechnology | Major industry name |
| Sector Name | Healthcare | Sector name |
Market Info
| Parameter | Value | Description |
|---|---|---|
| Current Price | $1.80 | Current price of the stock |
| Trading Volume | $2M | Trading volume of the stock |
| Market Capitalization | $197.1M | Market capitalization of the company |
| Market Cap Category | Micro Cap | Category of market capitalization |
| Long-Term Growth Estimate | 22.22% | Long-term growth mean estimate |
| Analyst Rating Mean | 4.20 | Mean analyst rating |
| Potential Upside | 343.55% | Potential price appreciation based on analyst price targets |
| EPS Surprise Percentage Difference | - | Percentage difference of EPS surprise |
Dividends
| Parameter | Value | Description |
|---|---|---|
| Dividend Change (1 Year) | - | Dividend change over 1 year |
| Dividend Rate | $0.00 | Shows the amount of dividend paid |
Balance Sheet
| Parameter | Value | Description |
|---|---|---|
| Total Debt to Equity Ratio | 0.01 | Total debt to total equity ratio |
| Current Ratio | 4.16 | Current ratio |
Company Profitability
| Parameter | Value | Description |
|---|---|---|
| Gross Profit Margin | - | Gross profit margin |
| Operating Profit Margin | 0.00% | Operating profit margin |
| EBIT Margin | 0.00% | Earnings before interest and taxes (EBIT) margin |
| EBITDA Margin | - | Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin |
| Pretax Profit Margin | - | Pretax profit margin |
| Net Profit Margin | 0.00% | Net profit margin |
| Return on Equity (ROE) | -1.74% | Measures profitability relative to shareholders' equity |
| Return on Tangible Equity | -189.17% | ROE excluding intangible assets |
| Return on Assets (ROA) | -78.25% | Measures profitability relative to total assets |
| Return on Invested Capital (ROIC) | -188.25% | Measures profitability relative to invested capital |
Management Effectiveness
| Parameter | Value | Description |
|---|---|---|
| Asset Turnover (quarterly) | - | Asset turnover ratio |
| Inventory Turnover (quarterly) | - | Inventory turnover ratio |
| Receivables Turnover (quarterly) | - | Receivables turnover ratio |
| Days Sales Outstanding | - | Average number of days it takes to collect receivables |
Valuation Measures
| Parameter | Value | Description |
|---|---|---|
| Price-to-Earnings (P/E) Ratio | -3.91 | Measures valuation relative to earnings |
| Forward P/E Ratio | 0.00 | P/E based on future earnings estimates |
| Price-to-Sales (P/S) Ratio | 1014.87 | Measures valuation relative to sales |
| Price-to-Book (P/B) Ratio | 9.77 | Measures valuation relative to book value |
| Price-to-Operating Cash Flow (P/OCF) Ratio | -1.51 | Measures valuation relative to operating cash flow |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.51 | Measures valuation relative to free cash flow |
Cash Flow Statement
| Parameter | Value | Description |
|---|---|---|
| Net Acquisitions/Divestitures | 0 | Indicates company's M&A activity |